Zentalis Pharmaceuticals, Inc.
ZNTLNASDAQHealthcareBiotechnology
Previous close
$3.825
−$0.015 · -0.39%
Aug 21, 4:00 PM ET
Pre-market
$3.90
+$0.075 · +1.96%
Aug 24, 4:44 AM ET
ZNTL company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
42/100
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
27
Expensive
Momentum
79
Gaining
Sentiment
70
Bullish
Risk resilience
33
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
Market position
Day range
Current $3.825
$3.815$3.95
52-week range
Current $3.825
$1.212$6.95
- Open
- $3.95
- Previous close
- $3.84
- Volume
- 741.8K
- Market cap
- 272.29M USD
- 50-day average
- $4.3339
- -11.74% below average
- 200-day average
- $3.1297
- +22.22% above average
Financials
Financial statements
Income trends
Operating income
−152.81M USD+20.08%
Net income
−137.06M USD+17.35%
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 67.43M USD | — | — | — |
| Gross profit | — | 67.43M USD | — | — | — |
| Research and development | 107.3M USD | 167.77M USD | 235.16M USD | 172.73M USD | 175.6M USD |
| Selling, general, and administrative | 37.72M USD | 87.12M USD | 59.4M USD | 54.55M USD | 40.94M USD |
| Operating expenses | 152.81M USD | 258.62M USD | 299.51M USD | 227.29M USD | 216.54M USD |
| Interest income | — | — | — | 2.26K USD | — |
| Interest expense | — | — | — | 2.58M USD | — |
| Depreciation and amortization | 739K USD | 1.29M USD | 1.39M USD | 1.43M USD | 544K USD |
| Operating income | −152.81M USD | −191.19M USD | −299.51M USD | −227.29M USD | −216.54M USD |
| Net income | −137.06M USD | −165.84M USD | −292.19M USD | −236.81M USD | −158.73M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$8.33
117.78% upsidePast 12 months12-month forecastHigh $10.00Average $8.33Low $5.00
Rating distribution
12 ratingsStrong buy00%
Buy867%
Hold433%
Sell00%
Strong sell00%
ZNTL peers
ETFs holding ZNTL
Funds reporting this stock among their holdings, ordered by reported position size.
ETFMarket valueWeightAUMExpense ratioPrice / 1D
Vanguard Morningstar Total Stock Market ETFVTI10.37M0.00%2.3T USD0.03%$378.24—
iShares Russell 2000 ETFIWM4.68M0.01%81.62B USD0.19%$299.96—
Vanguard Extended Market ETFVXF2.73M0.00%93.7B USD0.05%$245.53—
Fidelity Enhanced Small Cap ETFFESM2.18M0.03%6.03B USD0.28%$47.94—
iShares Russell 2000 Value ETFIWN1.85M0.01%14.66B USD0.24%$224.81—
Vanguard Russell 2000 ETFVTWO1.33M0.01%17.4B USD0.06%$121.25—
Vanguard Health Care ETFVHT721.92K0.00%20.9B USD0.09%$327.7—
iShares Micro-Cap ETFIWC666.55K0.04%1.53B USD0.60%$198.39—Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 10.37M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24—
iShares Russell 2000 ETFIWM- Market value
- 4.68M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96—
Vanguard Extended Market ETFVXF- Market value
- 2.73M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53—
Fidelity Enhanced Small Cap ETFFESM- Market value
- 2.18M
- Weight
- 0.03%
- AUM
- 6.03B USD
- Expense ratio
- 0.28%
- Price / 1D
- $47.94—
iShares Russell 2000 Value ETFIWN- Market value
- 1.85M
- Weight
- 0.01%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81—
Vanguard Russell 2000 ETFVTWO- Market value
- 1.33M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25—
Vanguard Health Care ETFVHT- Market value
- 721.92K
- Weight
- 0.00%
- AUM
- 20.9B USD
- Expense ratio
- 0.09%
- Price / 1D
- $327.7—
iShares Micro-Cap ETFIWC- Market value
- 666.55K
- Weight
- 0.04%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39—
Continue in GoAI
Research ZNTLresearch.disclaimer